Stroke, Complication
Conditions
Brief summary
Background: Biofeedback-Surface electromyography (BIO-SEMG) is a relatively recent physiotherapy technique. Although its use is widespread in sports science and sports performance, its use for the rehabilitation of patients with neurological pathologies is less studied. Objective: The purpose of this research was to determine the changes that occur in the application of BIO-SEMG in the muscles responsible for the extension and the dorsiflexion of the hand and the foot in subjects with cerebrovascular damage. Design: A randomized, double-blind, two-arm parallel group study was performed. Patients: A sample of 28 subjects with limited extension of the hand and dorsiflexion of the foot as a consequence of a stroke was randomized divided in intervention or control groups. Methods: The subjects of the intervention group underwent 12 sessions of BIO-SEMG, of 15-minute duration each of them, in the upper and lower members. On the other hand, the control group underwent another 12 sessions of 15-minute duration, in which manual physiotherapy techniques were performed.
Interventions
DEVICEsurface electromyography-biofeedback
Two electrodes were putted on the motor point of the extensor muscle of the hand and the foot. The positive electrode was placed on the distal zone of the hand or the foot, while the negative electrode was placed on the proximal zone.
Sponsors
Universidad Católica San Antonio de Murcia
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)
Eligibility
Sex/Gender
ALL
Age
74 Years to 84 Years
Healthy volunteers
No
Inclusion criteria
* Patients with a stroke * Limitation of the hand and foot extension
Exclusion criteria
* Patients with some contraindication against the surface electromyography biofeedback technique, for instance, people with pacemaker, with cardiovascular antecedents, etc. * Patients receiving other physiotherapy treatment 2 months before the beginning of the study * Patients that decline to sign the informed consent.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Extension Degree | 3 months | Change in the extension ability of the upper an lower members depending on the activity of the extensor muscles |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Fugl Meyer Test | 6 months | Severity degree of the stroke-derived consequences |
Countries
Spain
Outcome results
None listed